Audra Moran, President and CEO at Ovarian Cancer Research Alliance, shared a post on LinkedIn:
“Honored to accept a Leadership award on behalf of Laura Shawver, Ph.D., last night at the Fierce 50 Awards Gala in NYC.
As CEO, Dr. Shawver most recently oversaw the acquisition of Capstan Therapeutics by AbbVie. As the founder of the Clearity Foundation, which recently joined the Ovarian Cancer Research Alliance’s family, she has long promoted bridging research and real-world patient impact, ensuring the best science and care is available to all.
Thank you to Fierce Pharma for recognizing her outstanding accomplishments. Congratulations to all the honorees, including my seatmate, Dr. Eric Green, a giant in the field of genomics, and Dr. Michelle Morse, acting Health Commissioner and CMO of the NYC Dept of Health and Mental Hygiene, both of whom also served as excellent panelists.”
More posts featuring Audra Moran.
